Review of Operations DELIVERING VALUE INOVIQ’s vision is to be a leading exosome and precision diagnostics company delivering next-generation products to improve patient health outcomes and help save lives. Currently, the Company has multiple proprietary technologies, inmarket products and a strong development pipeline of exosome research tools and precision diagnostics. INOVIQ is leveraging its core technology platforms to drive intelligent innovation in the diagnostic and exosome markets to develop a portfolio of best-in-class products that deliver value to patients, clinicians, the health system and investors. The Company has 3 key business pillars built around our disruptive technologies that underpin its short and longer-term product development and revenue generating opportunities: 1. Research tools and services: The EXO-NET technology is a source of multiple current and future revenue streams including EXO-NET research tools sold for research purposes, custom EXO-NET products and EXO-NET services to develop exosome-based diagnostics for contract research fees and future licensing revenue; 2. Precision diagnostics: INOVIQ’s diagnostic pipeline includes our current and future focus on both internal and partnered diagnostic tests developed using our SubB2M and EXO-NET technologies for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases; and 3. Therapeutics: The longer-term plan focuses on developing high-value exosome-based therapeutics for cancer, enabled by our EXO-ACE technology for therapeutic exosome isolation, purification and production. The Company’s strategic focus and three business pillars supporting our current and future initiatives are outlined below: INOVIQ’s three business pillars focus on growing long-term shareholder value through commercialisation of the Company’s lead diagnostics, building a multi-product pipeline, diversifying risk across multiple applications and creating a sustainable revenue generating business. STRATEGIC FOCUS Leading exosome solutions and precision diagnostics company focused on improving patient outcomes for cancer RESEARCH TOOLS & SERVICES DIAGNOSTICS THERAPEUTICS Exosome therapeutics SubB2M diagnostics Exosome diagnostics hTERT test EXO-NET products EXO-NET services DISRUPTIVE TECHNOLOGY SubB2M technology for enhanced cancer detection EXO-NET immunoaffinity magnetic bead-based exosome isolation EXO-ACE ion exchange chromatography for therapeutic exosome production 8 INOVIQ Limited
RkJQdWJsaXNoZXIy MjE2NDg3